Vertex Pharmaceuticals
VRTX
#167
Rank
$133.06 B
Marketcap
$525.34
Share price
-0.26%
Change (1 day)
32.89%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): $5.04 Billion USD

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are $12.58 Billion USD. In 2025 the company made an earning of $4.82 Billion USD, an increase over its 2024 earnings that were of $0.27 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) $5.04 B4.61%
2025 $4.82 B1627.59%
2024 $0.27 B-93.69%
2023 $4.42 B3.19%
2022 $4.28 B53.56%
2021 $2.79 B-12.06%
2020 $3.17 B118.45%
2019 $1.45 B120.64%
2018 $0.65 B1473.64%
2017 $41.86 M197.6%
2016 $14.06 M-102.97%
2015 -$0.48 Billion-28.46%
2014 -$0.67 Billion-51.5%
2013 -$1.37 Billion-30584.68%
2012 $4.47 M-95.47%
2011 $98.89 M
2009 -$0.6 Billion
2007 -$0.42 Billion83.1%
2006 -$0.23 Billion59.02%
2005 -$0.15 Billion3.28%
2004 -$0.14 Billion-38.16%
2003 -$0.23 Billion
2000 -$38.05 Million-20.38%
1999 -$47.78 Million31.62%
1998 -$36.3 Million91.05%
1997 -$19 Million-36.24%
1996 -$29.8 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
$26.20 B 419.60%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$8.69 B 72.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-$1.96 Billion-138.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$7.69 B 52.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$11.91 B 136.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-$50.22 Million-101.00%๐Ÿ‡บ๐Ÿ‡ธ USA